HK Stock MarketDetailed Quotes
00314 SIPAI HEALTH
- 5.230
- +0.080+1.55%
Market Closed Nov 8 16:08 CST
3.99BMarket Cap-15072P/E (TTM)
5.260High5.160Low459.40KVolume5.170Open5.150Pre Close2.40MTurnover0.06%Turnover RatioLossP/E (Static)763.47MShares8.60052wk High2.43P/B3.99BFloat Cap4.99052wk Low--Dividend TTM763.47MShs Float44.600Historical High--Dividend LFY1.94%Amplitude4.890Historical Low5.218Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
SIPAI HEALTH Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q3)Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -3.04%2.36B | 14.39%4.71B | 29.15%2.44B | 18.58%4.12B | 21.78%1.89B | 28.68%3.47B | --1.55B | 64.67%765.39M | 159.83%2.7B | --464.79M |
| Operating income | -3.04%2.36B | 14.39%4.71B | 29.15%2.44B | 18.58%4.12B | 21.78%1.89B | 28.68%3.47B | 1.55B | 64.67%765.39M | 159.83%2.7B | 464.79M |
| Cost of sales | 3.83%-2.13B | -13.62%-4.3B | -29.76%-2.22B | -18.54%-3.78B | -19.50%-1.71B | -26.97%-3.19B | ---1.43B | -58.79%-713.7M | -162.51%-2.51B | ---449.45M |
| Operating expenses | 3.83%-2.13B | -13.62%-4.3B | -29.76%-2.22B | -18.54%-3.78B | -19.50%-1.71B | -26.97%-3.19B | -1.43B | -58.79%-713.7M | -162.51%-2.51B | -449.45M |
| Gross profit | 4.97%228.93M | 22.93%414.7M | 23.25%218.09M | 19.02%337.35M | 49.34%176.94M | 51.69%283.45M | 118.48M | 236.88%51.69M | 128.42%186.86M | 15.35M |
| Selling expenses | 9.36%-137.82M | 12.18%-292.32M | 5.33%-152.05M | -14.20%-332.85M | -15.33%-160.61M | -58.88%-291.46M | ---139.27M | -97.40%-66.1M | -58.10%-183.45M | ---33.49M |
| Administrative expenses | 7.69%-161.89M | 39.52%-347.79M | 30.50%-175.38M | 14.18%-575.01M | 19.01%-252.33M | -85.48%-670.02M | ---311.54M | -87.21%-129.82M | -64.60%-361.24M | ---69.35M |
| Research and development expenses | 37.09%-15.01M | 26.66%-45.95M | 30.40%-23.86M | -5.82%-62.65M | -17.00%-34.29M | -29.43%-59.21M | ---29.31M | -37.13%-13.06M | -84.08%-45.74M | ---9.52M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,108.28%-1.42B | ---- | ---117.58M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,108.28%-1.42B | ---- | ---117.58M |
| Impairment and provision | -79.93%-3.29M | -82.31%-9.97M | 63.44%-1.83M | 14.69%-5.47M | -81.60%-5M | -20.18%-6.41M | ---2.76M | 15.36%-1.97M | -188.94%-5.33M | ---2.33M |
| -Other impairment is provision | -79.93%-3.29M | -82.31%-9.97M | 63.44%-1.83M | 14.69%-5.47M | -81.60%-5M | -20.18%-6.41M | ---2.76M | 15.36%-1.97M | -188.94%-5.33M | ---2.33M |
| Operating interest expense | ---- | 13.66%-3.49M | ---- | -9.57%-4.04M | -4.10%-1.96M | -4.56%-3.69M | ---1.88M | -4.66%-943K | -22.59%-3.53M | ---901K |
| Special items of operating profit | -68.84%15.63M | -19.52%39.56M | 181.42%50.16M | 2.52%49.15M | -0.22%17.82M | 65.38%47.95M | --17.86M | 638.93%8.41M | 329.64%28.99M | --1.14M |
| Operating profit | 13.46%-73.45M | 58.68%-245.25M | 67.28%-84.87M | 15.14%-593.51M | 25.54%-259.42M | -82.40%-699.39M | -348.4M | -625.73%-1.57B | -38.67%-383.44M | -216.68M |
| Financing cost | 14.97%-1.55M | ---- | ---1.82M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Share of profits of associates | ---157K | -224.47%-412K | ---- | 141.61%331K | 123.68%81K | 310.77%137K | ---342K | -3,916.67%-229K | -111.09%-65K | --6K |
| Special items of earning before tax | ---- | ---- | ---- | 74.57%-775.26M | 96.07%-85.1M | -363.75%-3.05B | ---2.17B | ---- | -105.36%-657.34M | ---- |
| Earning before tax | 13.31%-75.16M | 82.05%-245.67M | 74.83%-86.7M | 63.49%-1.37B | 86.31%-344.44M | -260.06%-3.75B | -2.52B | -625.85%-1.57B | -74.63%-1.04B | -216.68M |
| Tax | 183.42%508K | 68.66%-1.04M | 60.61%-609K | -302.67%-3.32M | -4,168.42%-1.55M | 30.03%-825K | --38K | 121.62%32K | -2,211.76%-1.18M | ---148K |
| After-tax profit from continuing operations | 14.50%-74.65M | 82.02%-246.71M | 74.77%-87.31M | 63.41%-1.37B | 86.25%-345.99M | -259.73%-3.75B | -2.52B | -625.34%-1.57B | -74.82%-1.04B | -216.83M |
| Earning after tax | 14.50%-74.65M | 82.02%-246.71M | 74.77%-87.31M | 63.41%-1.37B | 86.25%-345.99M | -259.73%-3.75B | -2.52B | -625.34%-1.57B | -74.82%-1.04B | -216.83M |
| Minority profit | -29.18%3.55M | 860.15%9.06M | 1,374.71%5.01M | 85.19%-1.19M | 105.07%340K | -1,170.21%-8.05M | ---6.71M | -800.28%-2.54M | 150.95%752K | --362K |
| Profit attributable to shareholders | 15.29%-78.2M | 81.34%-255.77M | 73.34%-92.32M | 63.36%-1.37B | 86.20%-346.33M | -258.70%-3.74B | -2.51B | -622.97%-1.57B | -75.38%-1.04B | -217.19M |
| Basic earnings per share | 14.29%-0.12 | 96.72%-0.4 | 96.00%-0.14 | 67.59%-12.19 | 86.07%-3.5 | -260.59%-37.61 | -25.12 | -623.50%-15.7 | -75.29%-10.43 | -2.17 |
| Diluted earnings per share | 14.29%-0.12 | 96.72%-0.4 | 96.00%-0.14 | 67.59%-12.19 | 86.07%-3.5 | -260.59%-37.61 | -25.12 | -623.50%-15.7 | -75.29%-10.43 | -2.17 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data